| Heading: |
Methylphenidate: Shortages |
| Question ID: |
1816973 |
| UIN: |
63104 |
| House: |
Commons |
| Date tabled: |
2025-06-26 |
| Asking Member ID: |
5195 |
| Asking Member display name: |
Andrew Cooper
|
| Asking Member handle: |
goandrcoop
|
| Asking Member Twitter reference: |
@goandrcoop
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to work with manufacturers of Concerta XL to (a) resolve the ongoing supply shortages and (b) prevent disruption for patients reliant on this medication. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-03 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department can confirm that the supply disruptions affecting various strengths of Concerta XL, generic name methylphenidate, tablets have now been fully resolved. We continue to support the NHS England’s attention deficit hyperactivity disorder (ADHD)... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |